ArticleEuropean journal of clinical pharmacology2026
Cost-minimizing alternative dosage regimens of imipenem/cilastatin/relebactam for patients with renal impairment: a pharmacokinetic/pharmacodynamic simulation study.
Xiaoping Shi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.